Skip to content

Comparison of effect of Vaman with Shalmali kantak lepa and Virechan with Shalmali kantak lepa in Yuvan pidika (pimples) patients

A comparative clinical study to evaluate the efficacy of Vaman and Virechan alongwith Shalmali kantak lepa in Yuvan pidika w.s.r.to Acne Vulgaris

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040856
Enrollment
30
Registered
2022-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

Vaidya Yagya Dutt Sharma PG Ayurvedic College Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinical features of Yuvan pidika w.s.r to Acne Vulgaris. Patients of age group between 17 and 30 years irrespective of sex, religion, socioeconomic status and occupation will be taken. Patients who are fit for Vaman karma and Virechan karma according to classical texts.

Exclusion criteria

Exclusion criteria: Patients having pidika due to other kshudraroga and kustaroga. Pidika produced due to side effect of any drug applied earlier. Patients who are contraindicated for Vaman karma and Virechan karma mentioned in classical texts. Patients suffering from prameha,masurika.

Design outcomes

Primary

MeasureTime frame
Clinical assessment will be based on both subjective and objective parameters.The results will be classified as completely cured, marked relief, moderate relief,mild relief, unchanged. Timepoint: Day 1 Day 15 Day 30

Secondary

MeasureTime frame
Completely cured 100%relief,Marked relief more than 75%relief, Moderate relief 50%-75%relief,Mild relief 25%-50%relief, Unchanged upto 25%reliefTimepoint: Day30

Countries

India

Contacts

Public ContactDr Akhilanath Parida

Vaidya Yagya Dutt Sharma PG Ayurvedic College

tarinitirupati@gmail.com8249162982

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026